Home › Neuroblastoma › Pennsylvania
Pag-aaral pangklinika para sa Neuroblastoma sa Pennsylvania
16 pag-aaral para sa Neuroblastoma ang naghahanap ng mga kalahok sa mga site sa Pennsylvania.
Mga Lungsod sa Pennsylvania
Opisyal na teksto ng pag-aaral (English)
Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
- Children's Hospital of Philadelphia, Philadelphia
Nagre-recruit
Hanggang edad 17 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06831552Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
Nagre-recruitPhase 1/2
Hanggang edad 30 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06541262Naxitamab Enabled Transplant-Free Study in High-Risk Neuroblastoma
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
Nagre-recruitPhase 2
Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07932808PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
Nagre-recruitPhase 1
Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT04837547Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Geisinger Medical Center, Danville
- Children's Hospital of Philadelphia, Philadelphia
- at 2 pa
Nagre-recruitPhase 3
Hanggang edad 30 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06172296Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia
Nagre-recruitPhase 1/2
6 Months – 25 Years · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06395103PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
- Children's Hospital of Philadelphia, Philadelphia
Nagre-recruitPhase 1/2
Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Okt 6, 2026 · NCT06721689Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
Nagre-recruitPhase 2
Hanggang edad 22 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT02559778Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
Nagre-recruitPhase 2
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06540963Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
Nagre-recruitPhase 1/2
Hanggang edad 26 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06465199Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Geisinger Medical Center, Danville
- Penn State Children's Hospital, Hershey
- at 2 pa
Nagre-recruitPhase 3
365 Days – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Hospital of Philadelphia, Philadelphia
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Nagre-recruitPhase 1/2
12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04851119Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
Nagre-recruitPhase 2
12 Months – 21 Years · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT05489887SPEARHEAD-3 Pediatric Study
- Children's Hospital of Philedephia, Philadelphia
Nagre-recruitPhase 1/2
Edad 2 hanggang 21 · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05642455NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
- Children's Hospital of Philadelphia, Philadelphia
Nagre-recruitPhase 2
Edad 1 hanggang 31 · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT06450041Neuroblastoma Biology Study
- Children's Hospital of Philadelphia, Philadelphia
Nagre-recruitObservasyonal na pag-aaral
31 Days – 99 Years · Lahat ng kasarian · Na-update Mar 23, 2026 · NCT01587300Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.